Dept. of Ped., State Univ. of New York at Buffalo (introduced by David T. Karzon). Employing radioimmunodiffusion and autoradiography, poliovirus antibody levels in nasopharynx and serum were studied before and after tonsillectomy and adenoidectomy (T and A), in children previously immunized with live poliovaccine. Before T and A, yA poliovirus antibody was present in nasopharynx of all children, but no yG or yM antibody was detectable. Shortly after T and A, low levels of yG antibody appeared in nasopharynx of 50% of subjects. The response was short lived, and disappeared in 2 months. Significantly, however, pre-existing yA antibody in nasopharynx declined sharply after T and A in all children studied. Mean antibody titers decreased 3-to 4-fold, and individual titers in several children dropped 4-to 8-fold. Few children who had appreciable antibody levels in nasopharynx before T and A, failed to demonstrate any antibody activity in nasopharynx after T and A. Reduced or absent antibody activity persisted for as long as 8 months. Sharpest decline in antibody was seen in children 3 to 5 years of age, and in those, in whom the interval between polio immunization and T and A was less than 2 years. No significant change attributable to T and A was seen in serum antibody levels. In further studies, it was observed that following immunization with live poliovaccine, the response in nasopharynx was 2-to 4-fold higher in children with intact tonsils, than in those whose tonsils had been previously removed. These observations may provide an immunologic explanation to the known epidemiologic relationship of paralytic poliomyelitis and T and A. It appears that tonsils and adenoids may play a major role in nasopharyngeal antibody response to poliovirus, particularly in young children.
A Controlled Evaluation of the Effectiveness of Comprehensive Pediatric Care in Influencing Patient Compliance. LEON GORDIS and MILTON MARKOWITZ.
Hebrew Univ.-Hadassah Med. Sch., Jerusalem, and Univ. of Conn. Sch. of Med. Hartford, Conn. Non-compliance with physician's recommendations is a major problem in chronically ill children [Pediatrics 43: 173, 1969] and may prevent successful long-term medical management. A controlled study was therefore undertaken to determine if cooperation of children followed in the Johns Hopkins Rheumatic Fever Clinic might be improved by providing continuous and comprehensive pediatric care in place of specialty clinic care. 77 children on daily oral penicillin prophylaxi for history of rheumatic fever (RF) were selected for study. For 1 year, their compliance was determined by periodic urine tests for penicillin [Pediatrics 41: 152, 1968] . Patients were then stratified for age, sex and compliance and randomly allocated into comprehensive care (CC) and traditional care (TC) groups. CC patients received all medical care, even for problems unrelated to RF, from the same 2 physicians for 15 months. Night and weekend coverage was also provided. TC patients, on :the other hand, continued to receive traditional specialty clinic care and were seen at the RF clinic by different physicians in rotation. They were referred elsewhere for all problems unrelated to RF. Records were kept of all physician-patient contacts and urines were tested periodically for penicillin. At the end of 15 months there were no differences between the CC and TC groups in the proportion of non-compliers or in internal shifts in compliance which had occurred during the study period. These findings have important implications for the long-term management of chronically ill children and for evaluating the effectiveness of the many comprehensive child care programs currently being developed. (USPHS grant CH 00276.) and Med. Genet., Univ. of Pennsylvania. Human fibroblast cell cultures have been developed from fetuses and metabolically normal and abnormal non-fetal subjects. No differences have previously been described in the metabolic behavior of cultured cells of fetal and non-fetal origin.
For these studies cell lines derived from 6 non-fetal and 3 fetal skin samples were employed. The rate of glucose consumption, lactate production, and glycogen synthesis and degradation were measured. At medium concentrations between 50 and 200 mg%, the rate of glucose consumption was linear with time and cell concentration, and was essentially the same for both fetal and non-fetal cells. Glycogen metabolism was also the same in both cell types. Lactate production, however, was significantly less in the fetal lines.
In an attempt to determine the mechanism of the decreased lactate production in fetal lines, 14 CO 2 was measured using glucose-1-14 C, glucose-6-14 C and glucose-U-14 C. Fetal cells were found to produce significantly more CO 2 from the C-l carbon than from the C-6, while non-fetal cells did not differ in their CO 2 production from the C-l and C-6 of glucose. CO 2 production from galactose-l-14 C was the same in both cell types.
These studies show that metabolic distinctions between fetal and non-fetal cells persist in serial culture, and the cultures offer a tool for further characterization of these differences. [FRATANTONI et al., New Engl.J. Med. 280: 686, 1969] . Cultured cells have three major disadvantages: (1) the time and expense required for establishing tissue culture lines, (2) the large number of diseases showing metachromatic fibroblasts and (3) the difficulties in distinguishing heterozygous from homozygous individuals. Accordingly, a simplified method of analysis of mucopolysaccharides (MPS) in amniotic fluid was developed. The MPS content was determined in 40 samples of amniotic fluids from 12-to 22-week pregnancies leading to the delivery of normal infants. The average content of MPS was 0.02 mg per ml. An amniotic fluid from a 14-week pregnancy (furnished by Dr. H.NADLER) which resulted in the delivery of a patient with Hurler's syndrome showed 0.087 of mg of MPS per ml. Normal amniotic fluid contained 80% hyaluronic acid, 13% chondroitin-6-sulfate and 7% dermatan sulfate. The abnormal amniotic fluid contained 63% heparitin sulfate, a compound not detectable in the normal controls. The presence of increased amounts of heparitin sulfate could be detected directly by the nitrous, acid reaction for N-sulfated hexosamine. These results suggest that prenatal diagnosis of Hurler's syndrome can be carried out by a rapid and relatively simple method. Univ. of Wise. Med. Sch., Madison, Wise, (introduced by Arthur J.Moss). Intravascular coagulation (IVC) and abnormal fibrinolysis were studied in 232 patients with renal disease by means of: (1) serum fibrin split product (FSP) levels, (2) urine FSP levels, and (3) plasma coagulation and fibrinolytic assays, including screening tests (prothrombin, partial thromboplastin and thrombin times), coagulation factor assays (I, V, VIII and platelets) and fibrinolytic studies (euglobulin clot lysis time, plasminogen, antiplasmin, alpha-2-macroglobulin and alpha-1 -antitrypsin levels).
Serum FSP levels were elevated in acute glomerulonephritis (AGN), lupus nephritis (LN), hemolyticuremic syndrome and chronic glomerulonephritis (CGN) with uremia; there was no defibrination or abnormal fibrinolysis. Urine FSP were elevated in AGN, LN, CGN with uremia and nephrotic syndrome (NS). In NS, urine FSP may be secondary to fibrinogenuria. Two patients with TVC and defibrination with high serum FSP had normal urine FSP. Serum and urine FSP levels were not correlated, indicating that serum FSP are not excreted, that urine FSP originate from the kidney and that serum and urine FSP measure separate abnormalities.
Elevated factors I, V and VIII and prolonged thrombin times were present in AGN, LN and CGN with renal failure. Alpha-2-macroglobulin and antiplasmin levels were high and plasminogen levels were low in NS, indicating sluggish fibrinolysis and a propensity to thromboembolism.
Four groups of renal disease are delineated: a) no IVC (anaphylactoid purpura, CGN, urinary tract infection), b) no IVC but defective fibrinolysis (NS), c) localized IVC within the kidney (AGN, LN, transplant rejection), d) generalized IVC with kidney involvement (renal failure, hemolytic-uremic syndrome) . [New Engl.J. Med. 281: 923, 1969] . This term described impaired splenic reticuloendothelial function despite clinical enlargement of the organ. This defect was demonstrated by an isotopic scanning technique with 99mTc sulfur colloid. We can now describe studies which provide insight into the mechanism of functional asplenia. Infusions of fresh plasma did not restore function, indicating that functional asplenia is not a consequence of deficient opsonins or other humoral factors. Transfusions of normal red cells restored splenic activity in five children, and the level of Hgb S could be correlated with splenic function. The critical level of transfused normal red cells necessary for function was determined. Patients with sickle variants (Hgb AS, SC, S-thalassemia) had normal splenic function. The most likely mechanism is a mechanical one. The high viscosity of sickled cells may divert much of the splenic blood flow through AV shunts, thus bypassing the phagocytic R.E. elements of the sinusoids. We also have evidence of a dissociation of various functions of the spleen. One child with functional asplenia had thrombocytopenia which was corrected following splenectomy. Antibody response to heterologous red cell infusion was minimal in two children with functional asplenia and two children with return of splenic activity following transfusions. Splenic release of factor VIII and platelets following intravenous epinephrine infusions has also been studied. New York. In a longitudinal study of more than 400 children with congenital rubella (CR), rubella HI antibody was consistently detectable for the first three years of life; however, by age 5 years antibody had declined to undetectable levels in a significant minority of these children. A similar fall was not observed in their mothers. This raises further questions concerning the immunology of CR and limits the value of routine serologic screening among groups of children suspected of CR. In a survey of 3-to 9-year olds in 3 schools for the deaf, 54 (27%) of 200 deaf children had undetectable or equivocal levels of rubella HI antibody (titerŝ 1:8). In the same schools, 7 (28%) of 25 normal children had titers of ^ 1:8. Fifty of the deaf children were labeled as CR by parents or school officials; 20 (40%) of these children lacked detectable rubella antibody. Included were 8 of 18 children who have been followed in the 5-year study. Rubella virus vaccine (HPV-77DE 5 ) was administered to 12 children with CR whose titers were gjl:8. None of these children had antibody titer rises after 10 and 51 days; in contrast, seroconversion invariably followed vaccination of 'susceptible' normal children. These observations provide further insight concerning adaptive immunity in CR and suggest that failure of certain children to respond to rubella vaccine may be a useful tool for retrospective diagnosis of CR. Sch. of Med., and Univ. of Hawaii Sch. of Med. A critical question in immunization against rubella is the quality of immunity induced by the attenuated virus vaccines as compared with that resulting from natural infection. We have investigated this aspect by comparing reinfection rates in vaccines and natural immunes exposed in a rubella epidemic. The subjects were a company of military recruits from Hawaii, chosen because of the known high susceptibility rates among young adult residents of the Hawaiian Islands. The population consisted of 190 men, in the following groups with respect to immunity to rubella: 15 vaccine immunes who had been immunized two to three months previously; 149 natural immunes; and 26 susceptibles. Three weeks after the company was formed an epidemic of rubella occurred and spread through the group. All 26 susceptibles were infected, 9 with clinical rubella, and 17 inapparently. The virus was recovered from throat washings of 15 of these individuals. Reinfection rates determined by HAI and CF tests, were 80 % for vaccines and 1.3% for natural immunes. None of those reinfected became ill. The results indicate a striking difference between vaccine induced and naturally acquired immunity to rubella as a barrier to reinfection. They suggest that herd immunity may not be easy to achieve, and raise some doubts as to how sturdy the resistance of a young adult vaccinated in childhood will be, compared to that of one who experienced natural infection in the past.
Prognosis of Live Infants Who Have Had Intrauterine
Transfusions. WILLIAM COCHRAN, ANN STARK and CELIA SCHULHOFF. Harvard Med. Sch., Boston, Mass, (introduced by Charles Janeway). Fourty-one infants (of 42 discharged alive) who had had intrauterine transfusions were followed up once, ranging in age from 6 months to 4 54 years. Psychological,physicalandlaboratorytestswerecarriedouton these infants and, where thought appropriate, x-rays were taken. These 41 infants represented the 'end product' of 139 pregnancies during which the fetus received from one to four fetal transfusions. These infants averaged 34 weeks of gestation at birth. One set of twins survived. The one infant not followed up died of a sudden unexpected death at 3 months of age.
Thirty (73%) of these infants had normal physical and psychologic examinations and their creatinine, BUN, Hg and Hct were normal. One of these 30 turned out to be Rh negative; 6 infants (15%) had an abnormal physical examination, 50% of the findings being directly related to the intrauterine manipulation ; 2 of these 6 had definite evidence of renal damage; 4 infants (10%) had normal physical findings but low psychological scores; 1 was abnormal both physically and psychologically. Thus a total of 11 infants (27%) had an abnormal outcome. The prognosis for these 41 infants seems less ideal than that expected of comparable infants not undergoing fetal transfusion.
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Decreased Hosp., Dept. of Ped., Denver, CO (introduced by Henry K.Silver). The infant mortality rate of the total USA population is significantly higher than that of many European countries; the rate among low-income groups is even higher. Both of these have been of great concern among health professionals in the US. Infant mortality rates are considered a significant measure for comparing health status of populations. Infant mortality in 25 selected low-income census tracts in Denver was 33.1 per thousand live births in 1964, and in the 75 other census tracts was 24.1. The difference between the two rates is significant (p < 0.05). The rate in 1968 for the 25 low-income census tracts was 23.4 and in the other census tracts 20.0. The difference between those two rates is not statistically significant (p > 0.05). Thus, Denver succeeded in improving the infant mortality rates of its low-income population to the level of the mainstream of its population. Denver's approach to solving the health problems of its low-income population could, therefore, point the way toward solution of the same problems in other urban areas. In the five years covered by these data, Denver has developed a city-wide family-centered ambulatory care program providing health services to Denver's low-income population in ten decentralized locations in their communities.
The Denver Dept. of Health and Hosp. succeeded in blending % 7.5 million of federal funds from major grants (M and I, C and Y, OEO, PHS and Family Planning) to develop this program, avoiding fragmentation of care. Pediatric and prenatal visits increased severalfold in this time, influencing this decrease in infant mortality rates.
Cellular and Metabolic Alterations in Obese Rats Treated with Monosodium Glutamate During the
Neonatal Period. JEROME L. KNITTLE and FREDDA GINSBERG-FELLNER. The Mount Sinai Sch. of Med., Dept. of Ped., New York City (introduced by Richard L.Day). OLNEY demonstrated that monosodium glutamate (MSG) administered to newborn mice produces stunted skeletal development and marked obesity in the adult animal. Little is known, however, about the cellular ormetabolic basis of this form of obesity or if a similar effect can be achieved in other species. In the present report MSG was administered subcutaneously to newborn male Sprague Dawley rats daily for the first ten days of life. Untreated littermates served as controls. At 18 weeks of age the weight and cellularity of epidydimal fat pads was determined. The effect of epinephrine and insulin on in vitro glycerol release was also examined. The epidydimal fat pads from treated animals were significantly heavier than control animals: 3.4 g vs. 1.8 g. This increase in weight was due to a marked increase in cell size: 1.7 jMg/cell vs. control 0.3 ,ug/cell. The larger cells of the treated animals also displayed diminished responsiveness to the lipolytic effect of epinephrine and an increased responsiveness to the antilipolytic effect of insulin. More striking, however, is the fact that adipose cell number was significantly decreased in the treated group: 1.8X 10 6 cells vs. 3.8 X 10 6 cells per pad in controls. These findings indicate that the obese state produced by MSG administration is due to an increase in adipose cell lipid content which is maintained in part by altered lipolytic responsiveness to epinephrine and insulin. It is further postulated that treatment with MSG results in a permanent decrease in adult adipose cell number. Thus MSG may prove a useful tool in future studies of cell division during early growth.
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Defective We have now obtained direct evidence that the defect in B 12 -dependent MMA is an inability to synthesize deoxyadenosyl-B 12 . Skin fibroblasts from a child with the disease and from controls were grown in medium containing cobalt labeled hydroxo-B 12 ( 57 Co-hydroxo-B 12 ). After 3-5 days in culture, the intracellular B 12 compounds were extracted into ethanol and separated by thin layer chromatography. In control cells, 57 Co-deoxyadenosyI-B 12 was identified at concentrations of 0.06-0.57 pg/mg wet cell weight (x = 0.26; n = 12), but in the patient's cells, 5'Codeoxyadenosyl-B 12 was barely detectable with a range of 0.0-0.013 pg/mg (x = 0.006; n = 8). No defect in the synthesis of methyl-B 12 could be shown and the total uptake of 57 Co by control cells and the patient's cells was similar. Thus, in B 12 -dependent MMA, impaired coenzyme biosynthesis leads to defective holoenzyme function which can be partially corrected by large amounts of the coenzyme precursor. These findings establish one mechanism for understanding vitamin dependent diseases in man.
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Extending the Evaluation of the Effects of Early Enrichment. JULIUS B.RICHMOND and BETTYE M.
CALDWELL. Upstate Med. Center, Syracuse, NY, and Univ. of Arkansas. In 1964 the author and his colleagues began an enrichment program for infants and preschoolers. It is now well-established that the development of underprivileged infants begins to decline between 18 and 36 months. The enrichment model chosen was a group day-care program for children ranging in age from 6 months to 3 years. The enrichment package consisted of educational, health, and family service components. A few middle class children were always enrolled to provide for social integration, and the racial composition of the sample has always been regulated at approximately half white and half Negro. Early results were encouraging with respect to finding cognitive gains associated with participation in the program, and this paper will present follow-up data on children who have spent at least two years in the program. Gains found at the end of two years of participation were approximately half as large as those found at the end of the first year. Children who have been followed through the end of the Kindergarten years showed a decline between that period and the time of their last assessment in the program. No children who entered at age one or two have reached that point to date, however, so that it is still too soon to know whether enrichment begun earlier can produce more lasting gains. Data on the emotional development of the children who entered the program prior to age three and after that age revealed no significant differences in ratings of adjustment to people and materials and in general social competence. Implications of the data for social planning for community programs for children and families will be discussed. I ranged from 2 to a maximum cumulative dose of 32 mCi in 2 separate doses with average dose 6.6 mCi per patient. The mean length of follow-up is 9.2 years.
Prompt remission was obtained with a single dose in 25 cases. In 5, a second dose was necessary to restore euthyroidism. Permanent hypothyroidism developed in 8 patients (26 %), a figure in sharp contrast with the 81% incidence reported by STARR [STARR et al., J. nucl. Med. 10: 586, 1969] . Recurrence was observed in only 1 case in which 17 years after therapy with 130 I, hypermetabolism was associated with benign nodular hyperplasia. Twelve females treated with 131 I have given birth to 18 healthy children and 1 male is father of a normal child. One female treated with 130 I has an abnormal reproductive history; 2 pregnancies ended prematurely, one infant developing retrolental fibroplasia is retarded; the third and fourth pregnancies were normal but the child of the latter has hydrocephalus.
Use of radioiodine in children has justifiably been restricted to a selected population by apprehension that treatment doses may predispose to late development of thyroid cancer, leukemia or cause genetic damage. Together with other adequately reported series, follow-up information in 177 patients treated in childhood gives increasing assurance that m I treatment is not only simple to administer and efficacious but is to be rated with surgery and the antithyroid drugs in safety.
